Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Coop in connection with the acquisition of Netto’s Swedish grocery stores
Mandate

Vinge has advised Coop in connection with the acquisition of Netto’s Swedish grocery stores

May 16, 2019 M&A

Vinge has advised Coop Butiker & Stormarknader AB in connection with the acquisition of Netto’s Swedish grocery stores.

The transaction includes 163 grocery stores which will eventually be integrated and re-branded to Coop. Coop Butiker & Stormarknader AB operates 240 of Coop’s 650 grocery stores. The grocery stores are mainly located in Stockholm, Mälardalen, Östergötland and in the west of Skåne. The seller is Salling Group, Denmark’s largest consumer company, which, inter alia, operates Netto in Denmark, Germany, Poland and Sweden.
 
The acquisition is conditional upon customary closing conditions such as the approval of the Swedish Competition Authority.
 
Vinge’s team primarily consisted of responsible partners Daniel Rosvall and Niclas Winnberg together with, among others, associates Christoffer Nordin, Milad Kamali, Karolina Cohrs, Hampus Olsson, Valter Gran and VDR assistant Jessica Öijer. 
 

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025